Endo Investor Relations Material

Latest events

Q2 2025

Endo

Q2 2025

6 Aug, 2025

Q1 2025

7 May, 2025

Access the full event backlog

Slides, Transcripts, and Reports from 13,000 public companies

Request personal demo

Download app

Latest reports from Endo Inc

Access all reports

Endo Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic medicines. The company focuses on a range of therapeutic areas, including pain management, urology, and dermatology. It provides prescription medications, specialty pharmaceuticals, and sterile injectables to healthcare providers and patients. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.